Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Regenxbio and AbbVie: A Good Reason for RGNX to Soar Today

September 13, 2021 0

Regenxbio and AbbVie in the NEWS Regenxbio (RGNX) stock soared today. The Company, along with AbbVie …

Why IVERIC bio Stock Rallied Today

September 10, 2021 0

IVERIC bio Stock Rally IVERIC bio (ISEE) stock rallied in early, premarket trading today as Stifel …

Gain Therapeutics: A Biotech with Promising Treatments for Neurodegenerative Diseases and a Note from Prohost Biotech

September 8, 2021 0

Gain Therapeutics Inc in the News Gain Therapeutics, Inc. (GANX) announced today topline data from its …

Interesting, Good News for Impel NeuroPharma and Migraine Sufferers

September 3, 2021 0

Impel NeuroPharma FDA Approval for TRUDHESA The U.S. Food and Drug Administration (FDA) approved Impel NeuroPharma …

Can-Fite Biopharma Has Encouraging News but Will It Enthuse Investors?

September 2, 2021 0

Can-Fite Biopharma Good News We learned, from Petach Tikva, Israel, that Can-Fite Biopharma (CANF) – a …

Positive News for TCR2 Therapeutics – The U.S. FDA Granted Orphan Drug Designation to Gavo-Cel for Cholangiocarcinoma

September 2, 2021 0

TCR2 Therapeutics TCR2 Therapeutics (TCRR) is a clinical-stage cell therapy company developing a pipeline of novel T …

BioMarin Pharmaceutical Inc Product VOXZOGO® is the First to Prevent Dwarfism in Europe

August 31, 2021 0

The most important news in biological sciences is the high degree of success the biological revolution …

Cassava Statement Regarding Plasma p-tau Analysis from a Previously Disclosed Phase 2b Study in Alzheimer’s Patients

August 27, 2021 0

Cassava Sciences Released a Statement Cassava Sciences, Inc. (SAVA) – a biotechnology company focused on Alzheimer’s …

Agenus Good News: Balstilimab Monotherapy Data Published in Gynecologic Oncology

August 27, 2021 0

Agenus Good News for Balstilimab Monotherapy Agenus (AGEN) announced that results from a global Phase 2 …

Cassava Sciences Issued a Response to Claims Posted After Market Yesterday. See Also: Cassava Sciences Good News

August 25, 2021 0

Cassava Sciences Responds to Misleading Posts Cassava Sciences (SAVA) today issued a response to claims that …

Cara Therapeutics and Vifor Pharma Announced the U.S. FDA Approval of KORSUVA™

August 24, 2021 0

Cara Therapeutics and Vifor Pharma Granted US FDA Approval of KORSUVA™ Indeed, the U.S. Food and …

Axsome Therapeutics: Treating Major Depressive Disorder. Vivos Therapeutics: Improving the Treatment of Obstructive Sleep Apnea

August 23, 2021 0

Axsome Therapeutics Inc and Major Depressive Disorder In a teleconference on August 20, 2021, the U.S. …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Regenxbio and AbbVie: A Good Reason for RGNX to Soar Today

Why IVERIC bio Stock Rallied Today

Gain Therapeutics: A Biotech with Promising Treatments for Neurodegenerative Diseases and a Note from Prohost Biotech

Interesting, Good News for Impel NeuroPharma and Migraine Sufferers

Can-Fite Biopharma Has Encouraging News but Will It Enthuse Investors?

Positive News for TCR2 Therapeutics – The U.S. FDA Granted Orphan Drug Designation to Gavo-Cel for Cholangiocarcinoma

BioMarin Pharmaceutical Inc Product VOXZOGO® is the First to Prevent Dwarfism in Europe

Cassava Statement Regarding Plasma p-tau Analysis from a Previously Disclosed Phase 2b Study in Alzheimer’s Patients

Agenus Good News: Balstilimab Monotherapy Data Published in Gynecologic Oncology

Cassava Sciences Issued a Response to Claims Posted After Market Yesterday. See Also: Cassava Sciences Good News

Cara Therapeutics and Vifor Pharma Announced the U.S. FDA Approval of KORSUVA™

Axsome Therapeutics: Treating Major Depressive Disorder. Vivos Therapeutics: Improving the Treatment of Obstructive Sleep Apnea

The US FDA Granted Fast Track Designation for Sutro Biopharma Product STRO-002

Why Virpax Pharmaceuticals Stock Soared on Two Consecutive Days

BeiGene Ltd and EUSA Pharma Product QARZIBA® Approval from China NMPA. See Also: Sagimet Sciences and NASH

Travere Therapeutics: Positive Trial Results of its Product Sparsentan in Treating IgA Nephropathy

Akero Therapeutics Inc Q2 Business Updates and Financial Results

A Biotechnology Company to Remember and Appreciate

Reata Pharmaceuticals Two Stories: Updated News of its Clinical Programs and Finances

Agenus Inc Corporate Update and Financial Results for Q2 2021. See Also: Why Intellia Was Down Today